Drugs with this side effect as MedDRA Preferred Term
- 2-hydroxysuccinaldehyde
- 4-PBA
- 5-aza-2'-deoxycytidine
- Hypokalaemia: 12.1% - 21.7%
- 5-azacytidine
- Hypokalaemia: common, 1.71% - 13%
- 5-fluorocytosine
- Anidulafungin
- Hypokalaemia: 2.4% - 25.2%
- BCNU
- BPTI
- CGP 19835A
- Cancidas
- Carfilzomib
- Hypokalaemia: 0.57% - 13.7%
- FK463
- Hypokalaemia: 14% - 16.8%
- Fe(III
- Humalog
- Insulin
- L-Dmp
- LY146032
- Hypokalaemia: 9.17% - 12.9%
- Lutalyse
- Meropenem anhydrous
- PGE1
- Photofrin II
- Revasc
- Romidepsin
- SOM230
- Signifor
- Timentin
- Vallergan
- Vancocine
- abiraterone
- acetaminophen
- acetazolamide
- acyclovir
- afatinib
- Hypokalaemia: common, 2% - 11%
- allopurinol
- alvimopan
- ambrisentan
- aminophylline
- amphotericin B
- Hypokalaemia: postmarketing, 2.47% - 51.1%
- aprepitant
- aripiprazole
- arsenic
- arsenic trioxide
- Hypokalaemia: very common
- aspirin
- atropine
- belinostat
- bendamustine
- bendrofluazide
- betaxolol
- bexarotene
- boceprevir
- bortezomib
- bosentan
- budesonide
- bumetanide
- busulfan
- cabazitaxel
- cabozantinib
- candesartan cilexetil
- capecitabine
- capreomycin
- carbamazepine
- carboplatin
- carvedilol
- Hypokalaemia: 2.5% - 3.4%
- ceftaroline
- celecoxib
- cevimeline
- chlorthalidone
- Hypokalaemia: very common
- cidofovir
- Hypokalaemia: postmarketing
- cisplatin
- citalopram
- Hypokalaemia: postmarketing, rare
- clofazimine
- clomipramine
- conivaptan
- cortisol
- cosyntropin
- crizotinib
- cytarabine
- Hypokalaemia: 6.61% - 15.2%
- d-telaprevir
- dabrafenib
- dasatinib
- delamanid
- deprenyl
- desflurane
- Hypokalaemia: postmarketing
- desmopressin
- dexamethasone
- dexmedetomidine
- diazoxide
- dichlorphenamide
- disopyramide
- dobutamine
- donepezil
- doxazosin
- doxepin
- doxorubicin
- dronedarone
- efavirenz
- emtricitabine
- epinephrine
- eplerenone
- eprosartan
- eribulin
- erlotinib
- everolimus
- Hypokalaemia: common, very common, 2.07% - 12.9%
- exenatide
- febuxostat
- felbamate
- fenoldopam
- fentanyl
- fluconazole
- Hypokalaemia: postmarketing
- fluoxetine
- fluvoxamine
- fondaparinux
- Hypokalaemia: rare, 0% - 4.2%
- formoterol
- Hypokalaemia: postmarketing, rare
- fosaprepitant dimeglumine
- foscarnet
- fosphenytoin
- furosemide
- gadofosveset
- galantamine
- Hypokalaemia: postmarketing, infrequent
- ganciclovir
- gefitinib
- gemcitabine
- gentamicin
- glucose
- granisetron
- hydrocodone
- hydroxocobalamin
- ibuprofen
- Hypokalaemia: 0.987% - 13.3%
- icodextrin
- ifosfamide
- Hypokalaemia: postmarketing
- iloperidone
- imatinib
- Hypokalaemia: uncommon, 0.2% - 33.7%
- indacaterol
- indapamide
- Hypokalaemia: postmarketing
- irbesartan
- irbesartan-hydrochlorothiazide
- irinotecan
- isomannide
- isosorbide-5-mononitrate
- itraconazole
- Hypokalaemia: postmarketing, 0% - 29%
- ixabepilone
- ketorolac tromethamine
- lactulose
- lansoprazole
- leflunomide
- Hypokalaemia: uncommon, 1% - 3%
- lenalidomide
- Hypokalaemia: postmarketing, common, 2.24% - 13.6%
- leuprorelin acetate
- levosimendan
- linaclotide
- linezolid
- medroxyprogesterone acetate
- memantine
- meropenem
- mesna
- metaproterenol
- methadone
- metolazone
- mifepristone
- milrinone
- mitoxantrone
- morphine
- moxifloxacin
- mycophenolate mofetil
- Hypokalaemia: 8.3% - 41.1%
- mycophenolic acid
- nabumetone
- Hypokalaemia: postmarketing, 0.1%
- naproxen
- nelarabine
- nicardipine
- nilotinib
- Hypokalaemia: uncommon, common, 1% - 9%
- nisoldipine
- ofloxacin
- olanzapine
- olmesartan
- omeprazole
- Hypokalaemia: very rare, postmarketing
- ondansetron
- orlistat
- oxaliplatin
- Hypokalaemia: postmarketing, very common, 1% - 4%
- oxcarbazepine
- paclitaxel
- palonosetron
- pamidronate
- Hypokalaemia: common, 0% - 18%
- parecoxib
- paroxetine
- Hypokalaemia: rare, infrequent
- pergolide
- phenylbutyric acid
- phenytoin
- piperacillin
- poly(styrene sulfonate
- pomalidomide
- Hypokalaemia: 10.3% - 10.7%
- ponatinib
- posaconazole
- Hypokalaemia: 1.72% - 22%
- pralatrexate
- pramipexole
- prednisolone phosphate
- prednisone
- pregabalin
- propafenone
- propericiazine
- quetiapine
- rabeprazole
- rapamycin
- Hypokalaemia: postmarketing, 9% - 21%
- regorafenib
- remifentanil
- riluzole
- risperidone
- rivastigmine
- Hypokalaemia: infrequent, frequent
- ropinirole
- ropivacaine
- Hypokalaemia: 0.3% - 5.8%
- salbutamol
- Hypokalaemia: postmarketing, rare
- saquinavir
- sibutramine
- sildenafil
- sodium
- sodium acetate
- sodium bicarbonate
- sodium ferric gluconate
- sorafenib
- Hypokalaemia: postmarketing, common
- streptozotocin
- sunitinib
- tacrolimus
- Hypokalaemia: common, 13% - 34%
- tegaserod
- Hypokalaemia: postmarketing
- telavancin
- telithromycin
- telmisartan
- temozolomide
- temsirolimus
- tenofovir
- Hypokalaemia: postmarketing
- tenofovir disoproxil fumarate
- Hypokalaemia: postmarketing, uncommon
- terazosin
- testosterone
- Hypokalaemia: postmarketing
- thalidomide
- Hypokalaemia: postmarketing, 0% - 22.5%
- theophylline
- tiagabine
- tigecycline
- Hypokalaemia: 2.1% - 2.9%
- tizanidine
- tobramycin
- topiramate
- Hypokalaemia: postmarketing, infrequent
- torasemide
- trabectedin
- tramadol
- Hypokalaemia: postmarketing, uncommon, 0.3%
- trametinib
- treprostinil
- Hypokalaemia: 0.0316% - 9%
- triamcinolone acetonide
- triamterene
- valdecoxib
- valganciclovir
- vandetanib
- varenicline
- venlafaxine
- vismodegib
- voriconazole
- Hypokalaemia: common, 0% - 19.5%
- vorinostat
- x M22
- zalcitabine
- ziprasidone
- zoledronic acid
- Hypokalaemia: uncommon, 10% - 16%
- zonisamide
- zopiclone
|
Drugs with this indication
|